Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism GNA11 inhibitors(G protein subunit alpha 11 inhibitors), GNAQ inhibitors(G protein subunit alpha q inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uveal Melanoma | Preclinical | China | 11 Jun 2022 |